Argent Trust Co lowered its position in Cigna Corp (NYSE:CI) by 4.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,212 shares of the health services provider’s stock after selling 473 shares during the period. Argent Trust Co’s holdings in Cigna were worth $1,986,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also made changes to their positions in the company. Checchi Capital Advisers LLC lifted its holdings in Cigna by 1.2% in the fourth quarter. Checchi Capital Advisers LLC now owns 4,250 shares of the health services provider’s stock valued at $869,000 after acquiring an additional 49 shares during the period. Ironwood Investment Counsel LLC increased its holdings in shares of Cigna by 2.8% in the 4th quarter. Ironwood Investment Counsel LLC now owns 1,812 shares of the health services provider’s stock valued at $370,000 after purchasing an additional 49 shares in the last quarter. Whittier Trust Co. of Nevada Inc. lifted its stake in shares of Cigna by 1.1% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 5,010 shares of the health services provider’s stock valued at $1,025,000 after purchasing an additional 55 shares during the period. Waldron Private Wealth LLC boosted its holdings in Cigna by 3.0% during the fourth quarter. Waldron Private Wealth LLC now owns 1,944 shares of the health services provider’s stock worth $397,000 after buying an additional 56 shares in the last quarter. Finally, Glassman Wealth Services grew its position in Cigna by 17.4% during the fourth quarter. Glassman Wealth Services now owns 385 shares of the health services provider’s stock worth $79,000 after buying an additional 57 shares during the period. 89.71% of the stock is currently owned by institutional investors.
Several brokerages have recently commented on CI. Deutsche Bank decreased their price target on Cigna from $288.00 to $279.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. ValuEngine cut Cigna from a “hold” rating to a “sell” rating in a report on Thursday, February 6th. SunTrust Banks lowered their target price on Cigna from $280.00 to $240.00 and set a “buy” rating on the stock in a report on Monday, April 13th. Royal Bank of Canada lifted their price target on Cigna from $249.00 to $266.00 and gave the stock an “outperform” rating in a research note on Friday, May 1st. Finally, Raymond James boosted their price objective on shares of Cigna from $210.00 to $240.00 and gave the stock a “strong-buy” rating in a research report on Monday, May 4th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $241.43.
Shares of NYSE:CI traded up $0.32 during trading on Friday, reaching $189.00. The stock had a trading volume of 818,668 shares, compared to its average volume of 1,479,482. The business has a fifty day moving average price of $185.09 and a 200-day moving average price of $192.94. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.71. The stock has a market cap of $69.62 billion, a P/E ratio of 14.52, a PEG ratio of 0.92 and a beta of 0.68. Cigna Corp has a fifty-two week low of $118.50 and a fifty-two week high of $224.64.
Cigna (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $4.69 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $4.35 by $0.34. The firm had revenue of $38.39 billion for the quarter, compared to analyst estimates of $37.09 billion. Cigna had a net margin of 3.19% and a return on equity of 15.05%. Cigna’s revenue was up 14.8% compared to the same quarter last year. During the same quarter last year, the business earned $3.90 earnings per share. As a group, equities analysts forecast that Cigna Corp will post 18.41 EPS for the current year.
In related news, insider Timothy C. Wentworth sold 2,200 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an average price of $201.11, for a total value of $442,442.00. Following the sale, the insider now directly owns 70,943 shares of the company’s stock, valued at $14,267,346.73. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William L. Roper sold 2,819 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The shares were sold at an average price of $192.07, for a total transaction of $541,445.33. Following the completion of the sale, the director now owns 10,442 shares of the company’s stock, valued at $2,005,594.94. The disclosure for this sale can be found here. In the last ninety days, insiders sold 119,746 shares of company stock valued at $23,449,093. Company insiders own 0.90% of the company’s stock.
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Featured Article: Stock Market – What is a circuit breaker?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.